393 related articles for article (PubMed ID: 10594344)
1. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Stachura J; Pajdo R; Hahn EG
Eur J Pharmacol; 1999 Nov; 385(1):47-61. PubMed ID: 10594344
[TBL] [Abstract][Full Text] [Related]
2. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
3. Ischemic preconditioning, the most effective gastroprotective intervention: involvement of prostaglandins, nitric oxide, adenosine and sensory nerves.
Pajdo R; Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Sliwowski Z; Pawlik M; Ptak A; Drozdowicz D; Hahn EG
Eur J Pharmacol; 2001 Sep; 427(3):263-76. PubMed ID: 11567657
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
[TBL] [Abstract][Full Text] [Related]
5. Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves.
Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Pawlik WW
Eur J Pharmacol; 2004 Sep; 499(1-2):201-13. PubMed ID: 15363968
[TBL] [Abstract][Full Text] [Related]
6. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Drozdowicz D; Kwiecieñ S; Pajdo R; Bielanski W; Hahn EG
Eur J Pharmacol; 2000 Jun; 398(1):147-58. PubMed ID: 10856459
[TBL] [Abstract][Full Text] [Related]
7. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
Ukawa H; Yamakuni H; Kato S; Takeuchi K
Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
[TBL] [Abstract][Full Text] [Related]
8. Gastric preconditioning induced by short ischemia: the role of prostaglandins, nitric oxide and adenosine.
Konturek SJ; Brzozowski T; Pajdo R; Konturek PC; Kwiecień S; Sliwowski Z; Pawlik M; Ptak A; Drozdowicz D; Hahn EG
Med Sci Monit; 2001; 7(4):610-21. PubMed ID: 11433185
[TBL] [Abstract][Full Text] [Related]
9. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
11. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2.
Brzozowski T; Konturek PC; Konturek SJ; Schuppan D; Drozdowicz D; Kwiecień S; Majka J; Nakamura T; Hahn E
Digestion; 2001; 64(1):15-29. PubMed ID: 11549833
[TBL] [Abstract][Full Text] [Related]
12. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
13. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
[TBL] [Abstract][Full Text] [Related]
14. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
[TBL] [Abstract][Full Text] [Related]
15. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice.
Mizuno H; Sakamoto C; Matsuda K; Wada K; Uchida T; Noguchi H; Akamatsu T; Kasuga M
Gastroenterology; 1997 Feb; 112(2):387-97. PubMed ID: 9024292
[TBL] [Abstract][Full Text] [Related]
16. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.
Maricic N; Ehrlich K; Gretzer B; Schuligoi R; Respondek M; Peskar BM
Br J Pharmacol; 1999 Dec; 128(8):1659-66. PubMed ID: 10588920
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection delays healing of ischaemia-reperfusion induced gastric ulcerations: new animal model for studying pathogenesis and therapy of H. pylori infection.
Konturek SJ; Brzozowski T; Konturek PC; Kwiecien S; Karczewska E; Drozdowicz D; Stachura J; Hahn EG
Eur J Gastroenterol Hepatol; 2000 Dec; 12(12):1299-313. PubMed ID: 11192319
[TBL] [Abstract][Full Text] [Related]
18. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat.
Konturek PC; Brzozowski T; Kania J; Kukharsky V; Bazela K; Kwiecien S; Harsch I; Konturek SJ; Hahn EG
Scand J Gastroenterol; 2003 May; 38(5):468-76. PubMed ID: 12795455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
